Neurocrine Biosciences · 11 hours ago
Sr. New Product Commercialization Director
San Diego, CA
Full-time
Onsite
Director/Executive
$230K/yr - $314K/yr
13+ years expNeurocrine Biosciences is a leading neuroscience-focused biopharmaceutical company dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological disorders. The role involves providing commercial leadership and overseeing the development and implementation of commercialization strategies for assigned therapeutic areas, collaborating with cross-functional teams to ensure commercial success.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Provides strategic commercial leadership, oversees the development, and leads the implementation of commercialization strategies for assigned therapeutic areas, while collaborating with cross-functional teams to ensure alignment with company goals and strategies
Oversee the creation and execution of comprehensive disease state and product-specific commercial plans to support successful market entry and growth
Provide strategic leadership and guidance to the development teams, ensure effective commercial insights are incorporated to achieve commercialization objectives
Contribute to ongoing market intelligence and customer insights, driving collaboration with key internal and external stakeholders to support market acceptance and adoption of late-stage psychiatry assets
Represent the commercialization function in cross-functional meetings and presentations, effectively communicating commercial strategies and progress to senior leadership and external partners
Lead commercial development to maximize the value of assets, build and implement pre-commercial marketing plans, and plan and conduct market research and analyses to refine market understanding and customer needs
Create preliminary brand plans for specific products, develop and lead commercial advisory boards and Key Opinion Leader (KOL) engagements, and refine gap analyses, positioning, and value propositions within competitive frameworks
Generate customer insights and recommendations to inform clinical development, evidence generation needs, and other elements impacting product labeling and overall commercial viability
Work closely with internal Health Economics and Outcomes Research (HEOR) and Market Access teams to build appropriate evidence generation to support differentiation required for commercial success
Collaborate closely with senior core team leads, Advocacy, Finance, Supply Chain, and other stakeholders to ensure commercial success
Monitor competitive therapies of relevance to Neurocrine to allow development teams to react to new information by strengthening underlying product candidate profiles
May perform other duties as assigned
Qualification
Required
BS/BA degree in a scientific or related field AND 15+ years of experience in pharmaceutical/biotech commercialization, with a focus on late-stage psychiatry products
Master's degree or MBA AND 13+ years of similar experience noted above
Strong mentoring skills and leadership abilities to supervise lower levels and/or lead indirect teams, with the ability to motivate and inspire cross-functional teams to achieve commercial objectives
Excellent strategic thinking, analytical, and problem-solving abilities, with a data-driven decision-making approach
Outstanding communication and presentation skills, including strong written and oral communication abilities
Demonstrated cross-functional leadership and ability to partner with colleagues across business, regulatory, and scientific functions within an organization
Excellent teamwork, interpersonal skills, and leadership
Demonstrated ability to thrive in a fast-paced, dynamic environment and drive results amidst ambiguity and complexity
Experience working in a matrixed organization and navigating complex cross-functional dynamics
Influences internal/external business and/or industry issues that have an impact on Neurocrine
Exceptional command of data analytics, forecasting, and market research techniques with a proven ability to interpret market insights to guide strategic decision-making
Proven track record of successful product launches and commercialization strategies, with a deep understanding of the therapeutic landscape and market dynamics
Knowledge of new product commercialization/planning, prior brand marketing launch experience and/or experience leading and building brands
Knowledge of biotechnology or pharmaceutical market, including sales, marketing, pricing, reimbursement, and product development
Recognized Internal thought leader and deep expertise in a discipline
Requires broad, deep and comprehensive expertise in leading-edge theories and techniques for functional area
Applies ingenuity and creativity to problem analysis and resolution in complicated and/or novel situations
Proven ability to translate strategy into tactical plans and drive outcomes
Position will be in San Diego and remote work is not available, but Neurocrine offers some work-from-home flexibility
Benefits
Annual bonus with a target of 35% of the earned base salary
Eligibility to participate in our equity based long term incentive program
Retirement savings plan (with company match)
Paid vacation
Holiday and personal days
Paid caregiver/parental and medical leave
Health benefits to include medical, prescription drug, dental and vision coverage in accordance with the terms and conditions of the applicable plans
Company
Neurocrine Biosciences
Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.
1001-5000 employees
H1B Sponsorship
Neurocrine Biosciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (16)
2024 (9)
2023 (8)
2022 (2)
2021 (5)
2020 (6)
Funding
Current Stage
Public CompanyTotal Funding
$260MKey Investors
Venrock
2015-02-19Post Ipo Equity· $250M
2009-12-17Post Ipo Equity· $10M
1996-05-31IPO
Leadership Team
Matt Abernethy
Chief Financial Officer
D
Dimitri Grigoriadis
VP, Research
Recent News
BioWorld Financial Watch
2026-01-16
Company data provided by crunchbase